ID ALL-PO AC CVCL_1069 SY ALLPO; AllPO DR CLO; CLO_0001705 DR CLDB; cl5399 DR ArrayExpress; E-MTAB-783 DR ArrayExpress; E-MTAB-3610 DR cancercelllines; CVCL_1069 DR Cell_Model_Passport; SIDM00211 DR ChEMBL-Cells; CHEMBL3308227 DR ChEMBL-Targets; CHEMBL2366294 DR Cosmic; 910944 DR Cosmic-CLP; 910944 DR DepMap; ACH-002209 DR EGA; EGAS00001000978 DR GDSC; 910944 DR GEO; GSM1669596 DR GEO; GSM5137706 DR GEO; GSM5137750 DR IARC_TP53; 21173 DR ICLC; HTL01003 DR LINCS_LDP; LCL-1043 DR PharmacoDB; ALLPO_58_2019 DR PRIDE; PXD023662 DR PRIDE; PXD030304 DR PubChem_Cell_line; CVCL_1069 DR Wikidata; Q54749226 RX PubMed=9444945; RX PubMed=14671638; RX PubMed=20164919; RX PubMed=27397505; RX PubMed=30894373; RX PubMed=35354797; RX PubMed=35839778; CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Population: Caucasian. CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638; PubMed=35354797). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=910944). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0%; Native American=0.07%; East Asian, North=2.2%; East Asian, South=1.8%; South Asian=1.45%; European, North=52.99%; European, South=41.49% (PubMed=30894373). CC Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. ST Source(s): Cosmic-CLP=910944; ICLC=HTL01003 ST Amelogenin: X ST CSF1PO: 10,11 ST D13S317: 11,12 ST D16S539: 13 ST D21S11: 29,30 ST D5S818: 11,12 ST D7S820: 9,11 ST TH01: 6,7 ST TPOX: 8,9 ST vWA: 16,17 DI NCIt; C9140; Childhood B acute lymphoblastic leukemia DI NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged DI ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 4M CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 40 // RX PubMed=9444945; DOI=10.1016/S0145-2126(97)00092-1; RA Gobbi, Alberto RA Di Berardino, Cristina RA Scanziani, Eugenio RA Garofalo, Angela RA Rivolta, Anna RA Fontana, Giovanna RA Rambaldi, Alessandro RA Giavazzi, Raffaella RA Biondi, Andrea RT "A human acute lymphoblastic leukemia line with the T(4;11) RT translocation as a model of minimal residual disease in SCID mice."; RL Leuk. Res. 21:1107-1114(1997). // RX PubMed=14671638; DOI=10.1038/sj.leu.2403236; RA Drexler, Hans Gunther RA Quentmeier, Hilmar RA MacLeod, Roderick A.F. RT "Malignant hematopoietic cell lines: in vitro models for the study of RT MLL gene alterations."; RL Leukemia 18:227-232(2004). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). // RX PubMed=35354797; DOI=10.1038/s41467-022-29224-5; PMCID=PMC8967900; RA Leo, Isabelle Rose RA Aswad, Luay RA Stahl, Matthias RA Kunold, Elena RA Post, Frederik RA Erkers, Tom RA Struyf, Nona RA Mermelekas, Georgios RA Joshi, Rubin Narayan RA Gracia-Villacampa, Eva RA Ostling, Paivi RA Kallioniemi, Olli-Pekka RA Pokrovskaja Tamm, Katja RA Siavelis, Ioannis RA Lehtio, Janne RA Vesterlund, Mattias RA Jafari, Rozbeh RT "Integrative multi-omics and drug response profiling of childhood RT acute lymphoblastic leukemia cell lines."; RL Nat. Commun. 13:1691.1-1691.19(2022). //